BackTrinity Biotech Plc Overview

Trinity Biotech Plc Long Term Debt

Latest long-term debt for TRIB: $27M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$27.17M
72.35% YoYΔ $-71.10M vs prior year quarter

Peer trimmed avg / median

Loading

Trinity Biotech Plc Long Term Debt History

Loading

Trinity Biotech Plc vs. peers: Long Term Debt Comparison

Loading

Trinity Biotech Plc Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Trinity Biotech Plc (TRIB) FAQ

As of the most recent data (December 2025), TRIB shows a long-term debt of $27M. That compares with $98M in the prior-year period — down 72.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TRIB's long-term debt is now $27M (was $98M) — a 72.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Trinity Biotech Plc is outperforming or lagging.

Tracking TRIB's long-term debt over time shows whether Trinity Biotech Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $27M That compares with $98M in the prior-year period — down 72.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Trinity Biotech Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $27M) with ownership activity and broader fundamentals.

Trinity Biotech Plc's long-term debt is $27M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.